Patent holdings for IPC class C40B 40/02

Total number of patents in this class: 570

10-year publication summary

42
35
41
40
62
69
45
28
23
9
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc.
300
39
The Regents of the University of California
18943
17
The Governors of the University of Alberta
869
11
Massachusetts Institute of Technology
9795
8
President and Fellows of Harvard College
5792
8
Takeda Pharmaceutical Company Limited
2961
8
DuPont US Holding, LLC
113
7
Genentech, Inc.
3742
6
The Board of Trustees of the Leland Stanford Junior University
6054
6
Adimab, LLC
134
6
Affinity Biosciences Pty Ltd
10
6
Immunocore Limited
190
6
Yale University
2204
6
Adaptimmune Limited
179
5
The Governing Council of The University of Toronto,
1361
5
National Research Council of Canada
1545
5
Twist Bioscience Corporation
217
5
Arcellx, Inc.
33
4
BioAtla, LLC
51
4
Janssen Biotech, Inc.
1347
4
Other owners 404